However, an unsustained burst of cytolytic activity was generated rapidly in spleen of CBK recipients, whereas relatively little cytolytic activity was generated in Kp" spleen. This Indicates that effector T cells were not generated efficiently in spleen of Kf) recipients even though extensive T cell proliferation was taking place in this microenvlronment. Furthermore, activated donor T cells dispersed rapidly throughout primary and secondary lymphoid organs of Kp* recipients, whereas few T cells migrated from spleen in CBK recipients. Consequently, the course of CD8 + T cell responses and the anatomical distribution of activated T cells are profoundly Influenced by the nature of the antigenic microenvironment encountered In vivo. We conclude that T cells rapidly proliferate and acquire new tissue-homing characteristics but do not differentiate into cytolytic effector cells at the site of priming when they encounter myeloid cells expressing low levels of antigen In vivo.
Introduction
Naive T cells respond to contact with cells displaying antigen by undergoing a complex series of morphological, phenotypic and functional changes that result in the acquisition of altered growth, differentiation and tissue-homing characteristics (reviewed in 1, 2) . Initial contacts between naive T cells and antigen-presenting cells (APC) take place within secondary lymphoid organs that drain the site of primary pathological challenge. The adaptive immune system has evolved to maximize the probability that very low numbers of APC displaying foreign antigen will induce a rapid, effective and highly specific response against invading pathogens to prevent spread of infection. For most antigens, T cells with appropriate receptor (TCR) specificities are present at very low frequencies in the naive T cell repertoire Thus, initial contacts that result in specific immune responses in vivo must involve vanishingly small numbers of T cells and APC. Consequently, mimicking physiological microenvironments in which priming events take place is difficult to accomplish in vitro. To circumvent this, cognate antigens, in the form of peptides or virus have been introduced directly into TCR transgenic (TCR-Tg) mice or into non-transgenic mice harbouring a cohort of antigen-specific T cells from TCR-Tg mice (3) (4) (5) (6) (7) (8) (9) (10) so that subsequent T cell responses can be monitored relatively easily in vivo. Not surprisingly, route of antigen administration and antigen dose are critical factors that influence the vigour and course of T cell responses in vivo, and their ultimate outcome in terms of virus clearance, tolerance induction and development of T cell memory (3) . In most studies, a wide variety of different cell types were potentially able to present antigen to naive T cells because cognate antigen was either (i) expressed by many types of cell (5, (7) (8) (9) (10) or (ii) administered as a soluble peptide able to associate with all cells expressing appropriate surface MHC molecules (3, 4) . In this study we have introduced naive H-2K b -specific, CD8 + T cells from TCR-Tg donor mice (11) into recipient (H-2K b -Tg) mice that differ only in the tissue-specific pattern and level of H-2K b expression (11, 12) . The rationale for this experimental approach is to provide the means to investigate how T cell responses proceed in microenvironments that are similar to those in which immune responses to foreign antigens are initiated in vivo. In particular, we concentrated on events that occur in microenvironments where few cells other than myeloid cells express low levels of antigen. Our results indicate that the balance between T cell proliferation, differentiation and acquisition of altered tissue-homing characteristics is profoundly influenced by the pattern and level of antigen expression encountered in vivo.
Methods

Mice
CBA/Ca mice were bred at the National Institute for Medical Research. All transgenic mice were generated and bred at the NIMR under barriered conditions and according to regulations laid down by the UK Home Office. BM3 TCR-Tg mice used as a source of donor T cells have been described (11) . KP (12) and CBK (11) are H-2K b -Tg mice. All transgenic mice were generated using fertilized oocytes obtained by mating CBA/Ca mice. Consequently, all mice used in these experiments carry the same genetic background.
H-2hf expression
H-2K
b expression by different cell lineages in H-2K b -Tg mice (Table 1) was assessed directly by staining with H-2K b -specific antibodies or indirectly in a more sensitive bioassay in which cells were used to stimulate IFN-y secretion by BM3 splenocytes (11) . Expression by myeloid cells from bone marrow (11) or thymus (unpublished results) was tested after prolonged culture with granulocyte macrophage colony stimulating factor. Levels of H-2K b expression are much higher on myeloid cells from CBK mice than Kp mice (11 and unpublished results).
Adoptive transfer of TCR-Tg + T cells
Pooled spleen and lymph node cells (4X10 7 ) from BM3 TCRTg donor mice were injected into the tail vein of CBA mice or H-2K b -Tg mice. Mice were killed on subsequent days after transfer. At least three mice were injected per time point. Control studies revealed that BM3 T cells continued to circulate in secondary lymphoid organs of CBA recipients for > 100 days Throughout this prolonged period TCR-Tg + T cells remained small, neither increased nor decreased significantly in numbers and did not acquire characteristic markers of activation (e.g. CD44, data not shown).
Cytotoxicity assays
Ex vivo cytotoxic activity of splenocytes was assessed in a standard 51 Cr-release assay (11) . Tests were performed in triplicate in round-bottomed microtitre plates at respondertarget(A:T) ratios of 100. b -specific lysis in injected CBA mice is due entirely to donor BM3 TCR-Tg cells since no cytotoxic activity is detected in CBA mice after a 3 day mixed lymphocyte culture with CBK stimulator cells (unpublished results).
Cytofluorimetric analysis
Thymus, spleen, axillary and mesentenc lymph nodes were removed and cells teased out into medium. Cells (1X10 6 ) in PBS were stained at 4°C in the presence of 0.02% Na azide, 1% BSA. Anti-CD8-FITC (53-6.7) and anti-CD4-phycoerythrin (PE) (GK1.5) conjugates were obtained from Becton Dickinson (Mountain View, CA). Anti-TCR antibody ] was biotinylated according to standard procedures and developed with streptavidin-TriColor (CalTag, San Francisco, CA). Cells from spleen and mesenteric lymph nodes were stained for the following T cell activation markers: MEL-14-FITC (anti-Lselectin), PS/2-biotin (anti-VLA-4), FD44.1.8.2-FITC (anti-LFA-1), 7D4-FITC (anti-CD25) and IM7-1-FITC (anti-CD44, PharMingen, Cambridge Bioscience, Cambridge, UK). Cells were also stained with anti-CD8-PE (YTS, 169.4; CalTag) or anti-CD8-FITC and Ti-98 conjugated to biotin or FITC. Cells were analysed on a Becton Dickinson FACScan with four logarithmic scales. Viable lymphocytes for acquisition were selected using forward and side scatter characteristics (set by eye) Resulting profiles were analysed using Cell Quest software Markers were set on TCR-Tg 1^ and TCR-Tg" in 
Assessment of proliferation in vivo
For three-colour staining of CD8, TCR and 7-amino-actinomycin D (7AAD) (15) cells were stained as above in a mixture of FITC-conjugated anti-TCR-Tg [Ti-98 (14)] and anti-CD8-PE. After two washes in FACS medium cells were stained with 7AAD (1 ng/ml) in 0.3% saponin for 30 mm at room temperature.
Results
Proliferation of CDff 1 ' T cells in H-2K?-Tg mice
T cell responses in recipient CBK and Kp mice (Table 1) were analysed following adoptive transfer (i.v.) of pooled splenocytes and lymph node cells from BM3 (TCR-Tg) donor mice. Donor T cells in all secondary lymphoid organs and, in some cases, in primary lymphoid organs were characterized by cytofluorimetry using an anti-clonotypic [anti-TCR-Tg (14)] mAb and a number of other T cell markers. In addition, splenocytes were stained with a DNA intercalating dye, 7AAD (15) , to assess T cell proliferation and were tested for the ability to lyse labelled EL-4 target cells directly (ex vivo assay)
The progress of T cell responses was monitored for a period of 14 days in each case but here we concentrate on early events that occur from 3 to 6 days after adoptive transfer Three days after transfer, the total number of CD8 + T cells present in spleen of CBK and KB recipients had increased significantly ( Fig. 1 ) and most (-90%) T cells were of donor origin (i.e. TCR-Tg + ). In contrast, the splenic microenvironment of control CBA mice did not foster expansion of donor CD8 + T cells. Numbers of donor CD8 + T cells present in spleen were at least 10 times higher (2-3X10 7 ) in CBK and Kp than in control CBA (-2X10 6 ) recipients injected at the same time (Table 2 ). These numbers were three to four times higher than the total number of CD8 + T cells injected (~7x 10 6 ) showing that donor T cells had proliferated, rather than preferentially accumulated, in recipient spleen Confirmation that donor T cells were proliferating in CBK and Kp spleen was obtained by staining cells with 7AAD (Fig. 2) . On average, around a quarter of gated TCR-Tg + , CD8 + cells stained brightly (i.e. contained more than a diploid quota of DNA) with 7AAD 3 days after transfer This reveals that the majority of donor T cells in both recipients were proliferating Furthermore, few cells, if any, stained dull with 7AAD (i.e. contained less than a diploid quota of DNA) in either recipient, indicating that the majority of donor CD8 + T cells were viable and not undergoing apoptosis in spleen. The number of donor CD8 + T cells detected in spleen did not continue to increase at later times after transfer (Table 2) 
Differentiation of CD8+ T cells in H-2KP-Tg mice
Although the kinetics of CD8 + T cell expansion and subsequent contraction were comparable in CBK and Kp spleen, qualitative aspects of CD8 + T cell responses differed profoundly ( ). In contrast, TCR-Tg levels were unchanged, relative to naive BM3 T cells, in Kp recipients ( Fig. 1 and Table 2) . Reduction in the level of surface TCR expression following T cell activation has been described by others and appears to correlate with differentiation of T cells (16) . By this criterion T cell responses followed a different course in the two types of recipient mice. Further evidence confirming that T cells responded differently in CBK and Kp mice was obtained from analyses of cytolytic activity (ex vivo assay) and of cell surface phenotypes of donor T cells. Three days after transfer donor T cells in CBK spleen had differentiated into blast cells that lysed EL-4 (H-2 b ) target cells in an ex vivo killing assay (Fig. 3A) . Functional analyses carried out at later times revealed that the burst of cytolytic activity detected in CBK spleen 3 days after transfer was short lived and declined rapidly on subsequent days until no cytolytic activity was detected on day 6 (Fig. 3B) . This pattern of functional activity was not observed in Kp recipients. Three days after transfer splenocytes did not lyse EL-4 target cells ex vivo (Fig. 3A) even though >90% were of donor origin at this time. Furthermore a burst of cytolytic activity was not detected on subsequent days and activity remained low (<25% of controls) until 6 days after transfer These data reveal that the splenic microenvironment of Kp recipients is not conducive to rapid and efficient generation of cytolytic effectors in situ, and suggests that T cell responses follow a fundamentally different path in CBK and Kp spleen in terms of the relationship between proliferation and differentiation of CD8 + T cells.
Analyses of various cell surface markers were carried out to determine whether CD8 + T cells displayed phenotypic characteristics typical of naive or activated T cells. In CBK spleen 3 days after transfer CD8 + T cells displayed phenotypes characteristic of activated, differentiated T cells (Fig.  4) . Levels of IL-2R (CD25), VLA-4 (CD49d), pgp-1 (CD44), LFA-1 (CD11a) were elevated and levels of L-selectin (MEL- 14, CD62L) were decreased when compared with naive CD8 + T cells from control BM3 mice Similar changes in the levels of all surface markers analysed were detected on CD8 + T cells in Kp spleen indicating that these T cells were also activated. However, changes in surface levels of IL-2-R, pgp-1 and L-selectin were not as marked as in CBK spleen.
Tissue distribution of activated CD8* T cells
Failure to detect cytolytic activity in spleen of KB recipients might arise because activated T cells migrate from spleen in large numbers after priming and enter circulation relatively rapidly. Additionally, activated T cells may be retained more effectively in CBK than in KB spleen, perhaps because of the higher density of cells expressing antigen. To address these (17) . However, cytofluorimetric analyses of primary (bone marrow and thymus) and secondary lymphoid organs (mesenteric and axillary lymph nodes) revealed significant differences in the anatomical distribution of activated CD8 + T cells following adoptive transfer into CBK or KB recipients.
At the peak of donor T cell expansion in mesenteric lymph nodes (Table 3 , day 4) both the number and the proportion of donor CD8 + T cells found were much lower in CBK (~3x 10   6 and -20% respectively) compared to KB (~1.2X1O 7 and -95%) recipients. Thus, throughout the period when activated donor T cells were undergoing extensive proliferation and differentiation in CBK spleen very few donor T cells were found in the lymph nodes. This shows that few naive T cells circulated to the lymph nodes and/or most donor T cells did not leave the spleen after activation in CBK mice The majority of donor T cells in lymph nodes expressed low levels of TCRTg in CBK recipients (-95% at day 4) whereas most expressed high levels in KB recipients (-75% at day 4) This correlates with observations made in spleen and indicates that the distinctive pathways of differentiation observed in spleen also occur in other tissues. Presumably, this is a consequence of the different antigenic microenvironments encountered by donor T cells in all tissues. Large cohorts of donor T cells were found in thymus and bone-marrow of KB recipients 3 days after transfer (data not shown). In contrast, naive T cells did not circulate to primary lymphoid tissues in control CBA mice (data not shown). This is consistent with changes in the expression of surface markers associated with tissue homing (e.g. pgp-1, VLA-4, LFA-1 and L-selectin) and confirms that donor CD8 + T cells acquire altered tissue-homing characteristics as a result of activation in KB mice Donor T cells were not found in thymus of CBK recipients and only 3% of bone marrow cells were TCR-Tg + 3 days after transfer (data not shown). This may reflect a difference in homing characteristics of activated T cells in CBK mice but could also arise because few T cells migrate from spleen after activation in these recipients.
These data show that donor T cell expansion was largely confined to one organ, the spleen, in CBK recipients with comparatively few activated T cells migrating from spleen or being generated in situ'm other primary or secondary lymphoid tissues. This prominent sequestering of the T cell response suggests that the entire programme of T cell activation, proliferation and differentiation to produce cytolytic effector cells is induced by APC and the microenvironment prevalent in CBK spleen. In comparison, the T cell response observed in Kp recipients is not confined to spleen since activated T cells rapidly permeate all primary and secondary lymphoid organs. Nevertheless, as in CBK recipients, spleen is the initial epicentre of proliferation in K(3 recipients since peak expansion of donor CD8 + T cells is delayed by 1 day in peripheral lymph nodes. expressed is relatively low since expression was detected only by recourse to a sensitive bioassay (11) . In contrast, all cells express H-2K b in CBK mice at elevated levels (11,12, unpublished results) Presumably, encounters in vivo between APC displaying cognate (foreign) antigen and naive, antigenspecific T cells occur rarely and involve relatively low amounts of antigen, especially during initial priming stages. Furthermore, antigen is presented by myeloid cells that migrate to secondary lymphoid organs draining sites of infection or inflammation (18, 19) . In effect, our system allows us to increase enormously the number of encounters between APC displaying antigen and antigen-specific CD8 + T cells. To minimize potential artifacts arising from increases in the number of these encounters and for T-T collaboration, we titrated the number of splenocytes so that the minimum dose was introduced (4X10 7 ) that still allowed us to assess the functional state of T cells in vivo. At this dose ~7x10 6 -1 X10 7 CD8 + T cells are injected into recipients and these represent -2-3% of total CD8 + T cells in control CBA recipients. Furthermore, CBK recipients are effective controls for artifacts arising from increased T-T collaboration during T cell responses. With these factors in mind, we consider that T cell responses in Kp recipients take place under circumstances that are more realistic than those which prevail in CBK mice.
Discussion
The kinetics of donor T cell proliferation in spleen is almost identical in Kp and CBK recipients. We assume that rapid expansion is induced by splenic APC of myeloid origin since
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myeloid cells are potent stimulators of naive CD4 + and CD8 + T cells (1, 16, (18) (19) (20) (21) (22) (23) . However, the balance between proliferation and differentiation, as measured by phenotypic and functional criteria, differs profoundly In Kp spleen, relatively little cytolytic effector activity was detected, even though the organ contained a large number of activated donor CD8 + T cells. This cannot be explained by a slower rate of T cell proliferation since the burst of cytolytic activity detected in CBK spleen at day 3 occurred when similar numbers of activated donor T cells were present. Thus, T cell responses in CBK and Kp spleen are distinguished by a distinct difference in acquisition of effector function but not by the kinetics of T cell proliferation. Our observations suggest that terminally differentiated effector T cells are not generated in large numbers in secondary lymphoid tissues where priming takes place in vivo. Generation of cytolytic effector T cells in situ may compromise continuous stimulation of T cell responses since APC displaying antigen (which are therefore targets for cytolytic effectors) will be few in number during the early stages of an immune response.
One explanation for the absence of a burst of cytolytic activity in Kp spleen is that T cells did not differentiate along identical pathways in each recipient. However, donor T cells in CBK and Kp recipients displayed surface phenotypes typical of activated T cells, although levels of some surface markers analysed did differ. Alternative differentiation of T cells may occur if distinct signals were received by naive T cells as they entered the splenic microenvironments and/or as they underwent subsequent proliferation. At both stages there are tangible reasons why distinct signals may be provided in the two different microenvironments. b may explain why so many activated donor T cells migrated out of Kp spleen and found their way into primary and other secondary lymphoid tissues. Limited access to APC displaying antigen may also be a feature of T cell responses to foreign antigens in vivo since APC will induce rapid clonal expansion in their vicinity once they encounter appropriate naive T cells. Thus, differences in the nature of signals delivered at priming and/or subsequent stages in the T cell response provide potential explanations for the distinct pathways of differentiation observed in vivo.
An alternative explanation for our observations in Kp spleen is that activated donor T cells migrated rapidly from spleen before they had fully differentiated into cytolytic effector T cells. In this event, T cell differentiation could occur at similar rates in Kp and CBK mice except that rapid dispersal of activated T cells in Kp but not CBK mice resulted in a burst of cytolytic activity only when CBK splenocytes were tested. We cannot distinguish between this and an explanation based on alternative pathways of differentiation. However, it is striking that most donor T cells found in peripheral lymph nodes of Kp mice express high levels of TCR-Tg rather than the lower levels characteristic of fully differentiated cytolytic T cells observed in CBK spleen. This suggests that generation of cytolytic cells is at least partially compromised in Kp mice.
